The drugmaker has become a clear winner with its weight-loss drugs. Now, with a pill under development, the company should ...

Adults with obesity were more likely to achieve a 10% or greater weight loss at 1 year if they continued using their ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Obesity medications, once facing shortages, are now widely available. So how do consumers not get scammed into purchasing ...

Prenatal and early-life factors significantly influence childhood obesity trajectories, highlighting the need for early ...

Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...

More or Less is produced in partnership with the Open University. Presenter: Tim Harford Reporter: Lizzy McNeill Producer: ...

Rhythm Pharmaceuticals’ push to move obesity patients from jabs to tabs has stayed on beat. | Rhythm Pharmaceuticals’ push to ...

Rhythm now plans to seek input from U.S. and EU regulatory authorities on a late-stage trial design to advance Bivamelagon in ...

About 1 in 5 classified as overweight based on BMI alone considered to have obesity according to European society definition.

Maternal obesity doesn't just affect the health of a pregnant woman. It can also have effects on her child, increasing their ...

For years, people living with obesity have been given the same basic advice: eat less, move more. But while this mantra may ...